Navigation Links
NewCardio Completes $2.9 Million Private Placement
Date:9/18/2009

tion, visit www.newcardio.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are based are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or nonoccurrence of future events. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including the potential risks and uncertainties set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2008 and relate to our business plan, our business strategy, development of our proprietary technology platform and our products, timing of such development, timing and results of clinical trials, level and timing of FDA regulatory clearance or review, market acceptance of our products, protection of our intellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize our products, our assumptions regarding cash flow from operations and cash on-hand, the amoun
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dr. Dorin Panescu, NewCardios Chief Technology Officer, Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology Society
2. NewCardio Announces Master Services Agreement With Top-Three Contract Research Organization
3. Top-Five Global Pharmaceutical Company Names NewCardio as its Provider of Automated Thorough QT Solution
4. NewCardio to Present at CapStones Third Annual Small-Cap Investor Conference July 30
5. NewCardio Medical and Technology Team Presents Two Abstracts at Heart Rhythm Society Conference
6. NewCardio to Introduce Technology at Heart Rhythm Society Conference
7. NewCardio Leadership to Make Two Presentations at Drug Information Association Drug Safety Conference
8. NewCardio Elects Michael E. Hanson to Board of Directors
9. UPDATE: NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting
10. NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting
11. NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2014)... New York, New York (PRWEB) August 23, 2014 ... filings stemming from the 2012 GranuFlo and NaturaLyte ... federal multidistrict litigation underway in U.S. District Court, ... to an updated docket report issued by the ... August 15th, at least 2,028 claims are pending ...
(Date:8/23/2014)... According to the new research report, "Electronic ... - Regional Trends & Forecast to 2019," defines ... analysis and forecast of value individually. Along with ... by applications and geography are also discussed in ... and 26 figures spread through 234 pages and ...
(Date:8/23/2014)... 23, 2014 "When men sit down ... contact with the dirty water inside the bowl, the ... said one of two inventors from Naugatuck, and Bridgeport, ... developed this protective device." , They developed the IPSAFE ... including the water, bowl and seat. This minimizes exposure ...
(Date:8/23/2014)... York, New York (PRWEB) August 23, 2014 ... http://www.consumerinjurylawyers.com/wright-conserve-hip-replacement.html ) filed on behalf of individuals ... the Conserve hip replacement line continue to move ... of Georgia, Bernstein Liebhard LLP reports. According to ... established a bellwether trial program that would allow ...
(Date:8/23/2014)... New York, NY (PRWEB) August 23, 2014 ... Times (NYT) reported on a data breach suffered ... nationwide, that saw the compromise of 4.5 million records ... and social security numbers. According to Mandiant, who was ... attack emanated from an advanced group of cyber ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 4Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4
... certain but solutions less so, experts say, , , FRIDAY, April 24 ... hard to avoid. But for people in stressful jobs, it,s especially ... protect the heart. , That,s because stress not only has ... but also a second. , "Work stress is bad for ...
... Hope Considered ,Too Important Not To Be Heard,SAN MATEO, ... that "Light of Hope: Help for Children with Autism," ... debut internationally on Friday, April 24, Saturday, April 25 ... during the final week of World Autism Awareness ...
... 2009 Annual Meeting of ShareholdersMCKINNEY, Texas, April 24 TORCHMARK CORPORATION (NYSE: ... 2009 Annual Meeting of Shareholders, When: ... Where: http://www.videonewswire.com/event.asp?id=56940 , How: ... at the, ...
... 24 Pharmatech Oncology, Inc., a Research Management ... launch of their Data Management business unit to ... Oncology Data Management business unit is branded as ... Data Management business unit maintains and processes data ...
... Copenhagen, Denmark, Friday 24 April: HIV positive and ... transplant, according to new research presented today at EASL ... the Study of Liver in Copenhagen, Denmark. , The ... 1 and 5 years between HIV negative and HIV ...
... HealthYes!™ is bringing its life-saving mobile screening services to ... most medically-advanced, state-of-the-art equipment and techniques to screen its ... abdominal aortic aneurysm, osteoporosis, and peripheral artery disease. ... ...
Cached Medicine News:Health News:Work Strife Stresses the Heart 2Health News:Work Strife Stresses the Heart 3Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 2Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 3Health News:Pharmatech Oncology Launches New Data Management Business Unit 2Health News:HIV positive and HIV negative patients have similar survival rates following liver transplant 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 3
(Date:8/21/2014)... 2014  Aptuit LLC announces that Aptuit SSCI, ... , has enhanced its capabilities in the areas ... large molecules, including biologic drugs, metabolites, and polymers, ... mass spectrometer. In making the announcement, ... "The expanded large molecule capability enhances our early ...
(Date:8/21/2014)... Nektar Therapeutics (NASDAQ: NKTR ... results from its Phase 3 pivotal clinical trial ... factor VIII (rFVIII) treatment for hemophilia A based ... primary endpoint in reducing annualized bleed rates (ABR) ... arm. Top-line results from the prospective, ...
(Date:8/21/2014)... -- Publicis Groupe customer engagement agency Rosetta today ... Industry Group Leader, has been featured in the 2014 ... people in the life-sciences industry. Those chosen for this ... technology, creativity, strategy and medicine. Hartley ... its leading Rosetta Consulting practice. In 2012, she was ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Shannon Hartley Shines in PharmaVOICE 100 2
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... Letter (CRL) from the U.S. Food and Drug Administration ... for AZ-004 (Staccato® loxapine), submitted as Adusuve™ Staccato® (loxapine) ... is issued by FDA,s Center for Drug Evaluation and ...
... Ltd. (NYSE Amex: CPD ) announced today that ... Executive Officer following the resignation of Jitendra N. Doshi as ... 1, 2010, due to personal and health-related reasons. ... many contributions during his years of service to the Company, ...
Cached Medicine Technology:Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 2Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 3Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 4Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 5Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status 2Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status 3Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: